Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Identification of gp120 Residue His105 as a Novel Target for HIV-1 Neutralization by Small-Molecule

Journal Article · · ACS Med. Chem. Lett.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Science Foundation (NSF)
OSTI ID:
1836704
Journal Information:
ACS Med. Chem. Lett., Vol. 12, Issue (11)
Country of Publication:
United States
Language:
ENGLISH

References (22)

Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence January 2012
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women July 2010
The design of drugs for HIV and HCV December 2007
Structure-Based Design, Synthesis and Validation of CD4-Mimetic Small Molecule Inhibitors of HIV-1 Entry: Conversion of a Viral Entry Agonist to an Antagonist February 2014
Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents October 2019
Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State April 2009
An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity April 2019
Impact of HIV-1 Envelope Conformation on ADCC Responses April 2018
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions October 2014
The HIV-1 gp120 CD4-Bound Conformation Is Preferentially Targeted by Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Sera from HIV-1-Infected Individuals October 2014
Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins October 2016
Modulating HIV-1 envelope glycoprotein conformation to decrease the HIV-1 reservoir June 2021
Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4 September 2005
Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition January 2016
Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation March 2021
Optimization of CD4/gp120 Inhibitors by Thermodynamic-Guided Alanine-Scanning Mutagenesis: Optimization of Protein/Protein Inhibitors December 2012
Development of an Effective Scalable Enantioselective Synthesis of the HIV-1 Entry Inhibitor BNM-III-170 as the Bis-trifluoroacetate Salt October 2019
γ-Sultam-cored N,N-ligands in the ruthenium( ii )-catalyzed asymmetric transfer hydrogenation of aryl ketones January 2016
First Synthesis of 1-Phenyl-3-pyrrol-1-ylindan-2-carboxylic Acid, a New Scaffold of Potential Non-peptide Endothelin Receptor Antagonists August 1999
The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site June 2020
Structure of a V3-Containing HIV-1 gp120 Core November 2005
Catalytic Asymmetric Dihydroxylation December 1994